Concomitant Chemoradiotherapy in Pyriform Sinus Carcinoma
Authors:
- Thierry M. SchmittTSThierry M. Schmitt
- Andrei P. TimoshenkoATAndrei P. Timoshenko
- Pierre-Gilles SimonPSPierre-Gilles Simon
- Joanne de CornulierJCJoanne de Cornulier
- Marc DurandMDMarc Durand
- Aline GuillotAGAline Guillot
- Christian MartinCMChristian Martin
Open Access
- 1 April 2002
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 128 (4) , 384-388
Abstract
SQUAMOUS CELL carcinoma of the hypopharynx has one of the worst prognoses of all upper aerodigestive tract cancers, particularly for tumors arising in the pyriform sinus, the most frequent site of hypopharyngeal origin.1 Radiation therapy following surgery is the standard therapy. The strategy of combined chemoradiotherapy in the treatment of advanced resectable disease (to avoid mutilating surgery) is known as organ preservation.2 The objective of larynx preservation in patients with pharynx and larynx carcinoma was studied in 3 randomized trials with combined platinum-fluorouracil chemotherapy in a neoadjuvant setting: these regimens were able to preserve the larynx in nearly 23% of patients after 5 years of follow-up, with no significant difference in survival compared with the standard treatment, ie, surgery and postoperative irradiation.3-5 Findings in laboratory and clinical studies suggest that concomitant administration of platinum-based chemotherapy and irradiation seems to be more effective than sequential treatment.6,7 Previous studies have found advantages to using multiple fractions per day for radiation therapy.8,9 However, the standard chemoradiotherapy regimen in these conditions remains to be determined.Keywords
This publication has 13 references indexed in Scilit:
- MANAGEMENT OF THE NECK IN PATIENTS WITH HEAD AND NECK CANCER TREATED BY CONCURRENT CHEMOTHERAPY AND RADIATIONOtolaryngologic Clinics of North America, 1998
- Randomized trial of induction chemotherapy in larynx carcinomaOral Oncology, 1998
- A Novel Organ Preservation Protocol for Advanced Carcinoma of the Larynx and PharynxJAMA Otolaryngology–Head & Neck Surgery, 1996
- Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III TrialJNCI: Journal of the National Cancer Institute, 1996
- Chemoradiotherapy for Organ Preservation in Oral and Pharyngeal CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 1995
- Combined Radiochemotherapy with Carboplatin in the Treatment of Advanced Head and Neck CarcinomasOncology, 1993
- Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapyRadiotherapy and Oncology, 1992
- Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancerCancer, 1990
- Twice-a-day radiation therapy for cancer of the head and neckCancer, 1985
- Twice-a-day irradiation technique for squamous cell carcinomas of the head and neckCancer, 1985